Recent advances in oral oncology 2008; squamous cell carcinoma imaging, treatment, prognostication and treatment outcomes

Oral Oncology

Volumn 45, Issue 6, 2009, Pages

  Scully, Crispian ^a   Bagan, Jose V ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Cancer; Imaging; Oral; Prognosis; Quality of life; Surgery; Treatment

Indexed keywords

CANCER RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MOUTH CANCER; ONCOLOGY; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

AGE FACTORS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; HEAD AND NECK NEOPLASMS; HUMANS; MOUTH NEOPLASMS; NECK DISSECTION; OROPHARYNGEAL NEOPLASMS; PERIODICALS AS TOPIC; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY; RECONSTRUCTIVE SURGICAL PROCEDURES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 67349142343     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.12.011     Document Type: Review

References (56)

1. McKie C., Ahmad U.A., Fellows S., Meikle D., Stafford F.W., Thomson P.J., et al. The 2-week rule for suspected head and neck cancer in the United Kingdom: referral patterns, diagnostic efficacy of the guidelines and compliance. Oral Oncol 44 9 (2008) 851-856
2. Lingen M.W., Kalmar J.R., Karrison T., and Speight P.M. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 44 1 (2008) 10-22
3. Saran R., Tiwari R.K., Reddy P.P., and Ahuja Y.R. Risk assessment of oral cancer in patients with pre-cancerous states of the oral cavity using micronucleus test and challenge assay. Oral Oncol 44 4 (2008) 354-360
4. Yan S.K., Wei B.J., Lin Z.Y., Yang Y., Zhou Z.T., and Zhang W.D. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia. Oral Oncol 44 5 (2008) 477-483
5. Zimmermann B.G., and Wong D.T. Salivary mRNA targets for cancer diagnostics. Oral Oncol 44 5 (2008) 425-429
6. Gomes C.C., and Gomez R.S. MicroRNA and oral cancer: future perspectives. Oral Oncol 44 10 (2008) 910-914
7. Hass H.G., Schmidt A., Nehls O., and Kaiser S. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC) - potential implications for clinical management and treatment decisions. Oral Oncol 44 1 (2008) 78-85
8. Amelink A., Kaspers O.P., Sterenborg H.J., vanderWal J.E., Roodenburg J.L., and Witjes M.J. Non-invasive measurement of the morphology and physiology of oral mucosa by use of optical spectroscopy. Oral Oncol 44 1 (2008) 65-71
9. Maitland K.C., Gillenwater A.M., Williams M.D., El-Naggar A.K., Descour M.R., and Richards-Kortum R.R. In vivo imaging of oral neoplasia using a miniaturized fiber optic confocal reflectance microscope. Oral Oncol 44 (2008) 1059-1066
10. Furusawa J., Oridate N., Suzuki F., Homma A., Furuta Y., and Fukuda S. Initial CT findings in early tongue and oral floor cancer as predictors of late neck metastasis. Oral Oncol 44 8 (2008) 793-797
11. Kim M.R., Roh J.L., Kim J.S., Choi S.H., Nam S.Y., and Kim S.Y. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract. Oral Oncol 44 2 (2008) 148-152
12. VanCann E.M., Rijpkema M., Heerschap A., van der Bilt A., Koole R., and Stoelinga P.J. Quantitative dynamic contrast-enhanced MRI for the assessment of mandibular invasion by squamous cell carcinoma. Oral Oncol 44 12 (2008) 1147-1154
13. Khalil H.H., Elaffandi A.H., Afifi A., Alsayed Y., Mahboub T., and El-Refaie K.M. Sentinel lymph node biopsy (SLNB) in management of N0 stage T1-T2 lip cancer as a "same day" procedure. Oral Oncol 44 6 (2008) 608-612
14. Terada A., Hasegawa Y., Yatabe Y., Hyodo I., Ogawa T., Hanai N., et al. Intraoperative diagnosis of cancer metastasis in sentinel lymph node of oral cancer patients. Oral Oncol 44 9 (2008) 838-843
15. Krabbe C.A., Dijkstra P.U., Pruim J., van der Laan B.F., van der Wal J.E., Gravendeel J.P., et al. FDG PET in oral and oropharyngeal cancer.Value for confirmation of N0 neck and detection of occult metastases. Oral Oncol 44 1 (2008) 31-36
16. Brennan P.A., Oeppen R.S., Bater M.C., Khosla N., Davies B., Puxeddu R., et al. CT and duplex scanning: a comparison of imaging techniques for evaluation of the carotid tree in head and neck cancer patients. Oral Oncol 44 (2008) 1009-1013
17. Atabo A., and Bradley P.J. Management principles of head and neck cancers during pregnancy: a review and case series. Oral Oncol 44 3 (2008) 236-241
18. Kurita H., Sakai H., Kamata T., Koike T., Kobayashi H., and Kurashina K. Accuracy of intraoperative tissue staining in delineating deep surgical margins in oral carcinoma surgery. Oral Oncol 44 10 (2008 Oct) 935-940
19. Sebastian P., Thomas S., Varghese B.T., Iype E.M., Balagopal P.G., and Mathew P.C. The submental island flap for reconstruction of intraoral defects in oral cancer patients. Oral Oncol 44 (2008) 1014-1018
20. Bertino G., Benazzo M., Occhini A., Gatti P., Spasiano R., and Alessiani M. Reconstruction of the hypopharynx after free jejunum flap failure: is a second free jejunum transfer feasible?. Oral Oncol 44 1 (2008) 61-64
21. Smolka K., Kraehenbuehl M., Eggensperger N., Hallermann W., Thoren H., Iizuka T., et al. Fibula free flap reconstruction of the mandible in cancer patients: evaluation of a combined surgical and prosthodontic treatment concept. Oral Oncol 44 6 (2008) 571-581
22. Ad V.B., and Chalian A. Management of clinically negative neck for the patients with head and neck squamous cell carcinomas in the modern era. Oral Oncol 44 9 (2008) 817-822
23. Iype E.M., Sebastian P., Mathew A., Balagopal P.G., Varghese B.T., and Thomas S. The role of selective neck dissection (I-III) in the treatment of node negative(N0) neck in oral cancer. Oral Oncol 44 12 (2008) 1134-1138
24. Elsheikh M.N., Rinaldo A., Ferlito A., Fagan J.J., Suárez C., Lowry J., et al. Elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma:is dissection of sublevel IIB necessary?. Oral Oncol 44 3 (2008) 216-219
25. Dietl B., Marienhagen J., Kühnel T., Schreyer A., and Kölbl O. The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective. Oral Oncol 44 5 (2008) 504-508
26. McCaul J.A. The p53 pathway and radio- and chemosensitivity of SCCHN. Oral Oncol 44 12 (2008) 1091-1092
27. Hoffmann T.K., Sonkoly E., Hauser U., van Lierop A., Whiteside T.L., Klussmann J.P., et al. Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncol 44 12 (2008) 1100-1109
28. Freier K., Engel M., Lindel K., Flechtenmacher C., Mühling J., Hassfeld S., et al. Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients. Oral Oncol 44 2 (2008) 116-123
29. Miyazaki A., Kobayashi J., Yamamoto T., Kido Y., Takemura K., Abe M., et al. A single-institute phase I/II trial combining nedaplatin dose escalation with a fixed dose of docetaxel for induction chemotherapy of oral squamous cell carcinoma. Oral Oncol 44 5 (2008) 471-476
30. Xing F., Li S., Ge X., Wang C., Zeng H., Li D., et al. The inhibitory effect of a novel organoselenium compound BBSKE on the tongue cancer Tca8113 in vitro and in vivo. Oral Oncol 44 10 (2008) 963-969
31. Riechelmann H., Sauter A., Golze W., Hanft G., Schroen C., Hoermann K., et al. Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma. Oral Oncol 44 9 (2008) 823-829
32. Su C.C., Chung J.A., Hsu Y.Y., Huang S.J., and Lian I.B. Age at diagnosis and prognosis of oral cancer in relation to the patient's residential area: experience from a medical center in Taiwan. Oral Oncol 44 (2008) 1032-1038
33. Liu S.Y., Chang L.C., Pan L.F., Hung Y.J., Lee C.H., and Shieh Y.S. Clinicopathologic significance of tumor cell-lined vessel and microenvironment in oral squamous cell carcinoma. Oral Oncol 44 3 (2008) 277-285
34. Goutzanis L., Papadogeorgakis N., Pavlopoulos P.M., Katti K., Petsinis V., Plochoras I., et al. Nuclear fractal dimension as a prognostic factor in oral squamous cell carcinoma. Oral Oncol 44 4 (2008) 345-353
35. Chien C.Y., Su C.Y., Fang F.M., Huang H.Y., Chuang H.C., Chen C.M., et al. Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol 44 2 (2008) 174-179
36. Smith E.M., Wang D., Kim Y., Rubenstein L.M., Lee J.H., Haugen T.H., et al. P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol 44 2 (2008) 133-142
37. Chuang A.Y., Chuang T.C., Chang S., Zhou S., Begum S., Westra W.H., et al. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol 44 10 (2008) 915-919
38. Sawant S.S., Zingde S.M., and Vaidya M.M. Cytokeratin fragments in the serum: their utility for the management of oral cancer. Oral Oncol 44 8 (2008) 722-732
39. Silva S.D., Perez D.E., Alves F.A., Nishimoto I.N., Pinto C.A., Kowalski L.P., et al. ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes. Oral Oncol 44 5 (2008) 484-490
40. Shao Z., Zhang W.F., Chen X.M., and Shang Z.J. Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome. Oral Oncol 44 12 (2008) 1110-1117
41. Chiang W.F., Liu S.Y., Fang L.Y., Lin C.N., Wu M.H., Chen Y.C., et al. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma. Oral Oncol 44 4 (2008) 325-334
42. Saussez S., Lorfevre F., Lequeux T., Laurent G., Chantrain G., Vertongen F., et al. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy. Oral Oncol 44 1 (2008) 86-93
43. Sathyan K.M., Nalinakumari K.R., Abraham T., and Kannan S. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma. Oral Oncol 44 7 (2008) 689-697
44. Laimer K., Fong D., Gastl G., Obrist P., Kloss F., Tuli T., et al. EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features. Oral Oncol 44 1 (2008) 72-77
45. Blessmann M., Kaifi J.T., Schurr P.G., Cihan A., Kalinin V., Trump F., et al. Short tandem repeat polymorphism in exon 4 of esophageal cancer related gene 2 predicts relapse of oral squamous cell carcinoma. Oral Oncol 44 2 (2008) 143-147
46. Long N.K., Kato K., Yamashita T., Makita H., Toida M., Hatakeyama D., et al. Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas. Oral Oncol 44 (2008) 1052-1058
47. Tsai T.C., Yu C.H., Cheng S.J., Liu B.Y., Chen H.M., and Chiang C.P. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Oral Oncol 44 8 (2008) 759-766
48. Gao S., Krogdahl A., Sørensen J.A., Kousted T.M., Dabelsteen E., and Andreasen P.A. Overexpression of protease nexin-1 mRNA and protein in oral squamous cell carcinomas. Oral Oncol 44 3 (2008) 309-313
49. Penel N., Mallet Y., Roussel-Delvallez M., Lefebvre J.L., and Yazdanpanah Y. Factors determining length of the postoperative hospital stay after major head and neck cancer surgery. Oral Oncol 44 6 (2008) 555-562
50. Llewellyn C.D., Weinman J., and McGurk M. A cross-sectional comparison study of cognitive and emotional well-being in oral cancer patients. Oral Oncol 44 2 (2008) 124-132
51. Katre C., Johnson I.A., Humphris G.M., Lowe D., and Rogers S.N. Assessment of problems with appearance, following surgery for oral and oro-pharyngeal cancer using the University of Washington appearance domain and the Derriford appearance scale. Oral Oncol 44 10 (2008) 927-934
52. van den Berg M.G., Rasmussen-Conrad E.L., van Nispen L., van Binsbergen J.J., and Merkx M.A. A prospective study on malnutrition and quality of life in patients with head and neck cancer. Oral Oncol 44 9 (2008) 830-837
53. Scott B., Butterworth C., Lowe D., and Rogers S.N. Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a Maxillofacial Oncology clinic. Oral Oncol 44 5 (2008) 430-438
54. Bomeli S.R., Desai S.C., Johnson J.T., and Walvekar R.R. Management of salivary flow in head and neck cancer patients - a systematic review. Oral Oncol 44 (2008) 1000-1008
55. Brennan P.A. External carotid artery stenosis in patients with head and neck squamous cell carcinoma - a prospective study. Oral Oncol 44 3 (2008) 301-304
56. Roh J.L., Suh D.C., Kim M.R., Lee J.H., Choi J.W., Choi S.H., et al. Endovascular management of carotid blowout syndrome in patients with head and neck cancers. Oral Oncol 44 9 (2008) 844-850